Short description
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Description
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Gaithersburg, Maryland, United States, North America
Founded on
January 1, 2003
Exited on
January 10, 2014
Went public on
January 10, 2014
Stock symbol
GLYC
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Noaccess, Uh Ohhhh, Noway Youcantaccess, Noaccess, Noaccess, Nopepepe, Absolutely Noaccess
Sign in for full access
Founders
John Magnani, Rachel King